Jericho Financial’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.77M Sell
21,925
-56
-0.3% -$12.4K 3.01% 17
2025
Q4
$5.02M Sell
21,981
-1,847
-8% -$421K 3.03% 15
2025
Q3
$5.52M Buy
23,828
+725
+3% +$148K 3.35% 13
2025
Q2
$4.29M Sell
23,103
-177
-0.8% -$32.9K 2.83% 17
2025
Q1
$4.88M Buy
23,280
+2,154
+10% +$419K 3.54% 12
2024
Q4
$3.75M Buy
+21,126
New +$3.88M 2.72% 19

Other funds holding ABBV

Jericho Financial's ABBV Position: Q1 2026 in Review

Jericho Financial reduced its AbbVie (ABBV) stake by 0.25% in Q1 2026, selling an estimated $12.4K and leaving 21,925 shares worth $4.77M. The position accounts for 3.01% of the portfolio, ranked #17.

Jericho Financial first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. The position peaked at $5.52M in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Jericho Financial held 21,925 shares of AbbVie worth $4.77M as of Q1 2026.
  • Jericho Financial sold 56 AbbVie shares in Q1 2026, an estimated $12.4K.
  • AbbVie made up 3.01% of Jericho Financial's portfolio in Q1 2026, its #17 holding.
  • Jericho Financial first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
  • Jericho Financial's AbbVie position peaked at $5.52M in Q3 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Jericho Financial's 13F filing for Q1 2026, filed 29 Apr 2026.